Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial

Elias Jabbour, Hagop M. Kantarjian, Nitin Jain et al.|The Lancet Haematology|2022

Cited by 242